A photo of Cuixia Tian.

Cuixia Tian, MD


  • Neuromuscular Disease Specialist, Division of Neurology
  • Assistant Professor, UC Department of Pediatrics

About

Biography

Dr. Tian received her MD from the Medical Center of Fudan in 1993, and continued on there as a resident and chief resident until 1998.

From 1999-2003, she was a research fellow in the Department of Medicine at Vanderbilt University focusing on hematology and oncology.

Dr. Tian then became a research fellow from 2003-2008 at Vanderbilt in the Department of Pediatrics focusing on pediatric infectious disease.

In 2009, Dr. Tian became a pediatrics and neurology resident at Cincinnati Children’s Hospital Medical Center.

Additional Languages

Chinese

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab. Sherlock, SP; Palmer, J; Wagner, KR; Abdel-Hamid, HZ; Bertini, E; Tian, C; Mah, JK; Kostera-Pruszczyk, A; Muntoni, F; Guglieri, M; et al. Journal of Neurology. 2022; 269:4421-4435.

Obesity and loss of ambulation are associated with lower extremity oedema in Duchenne muscular dystrophy. Freytag, JM; Ryan, TD; Bange, JE; Bonarrigo, KC; Chouteau, WA; Wittekind, SG; Tian, C; Gao, Z; Villa, CR. Cardiology in the Young. 2022; 1-6.

Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls. Muntoni, F; Signorovitch, J; Sajeev, G; Goemans, N; Wong, B; Tian, C; Mercuri, E; Done, N; Wong, H; Moss, J; et al. Neuromuscular Disorders. 2022; 32:271-283.

Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. McDonald, CM; Marbán, E; Hendrix, S; Hogan, N; Ruckdeschel Smith, R; Eagle, M; Finkel, RS; Tian, C; Janas, J; Harmelink, MM; et al. The Lancet. 2022; 399:1049-1058.

The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid-induced osteoporosis. Nasomyont, N; Tian, C; Hornung, L; Khoury, J; Hochwalt, PM; Tilden, JC; Wong, BL; Rutter, MM. Muscle and Nerve. 2021; 64:710-716.

Emergency Planning as Part of Healthcare Transition Preparation for Patients with Duchenne Muscular Dystrophy. Chouteau, WA; Burrows, C; Wittekind, SG; Rutter, MM; Bange, JE; Sabla, GE; Rybalsky, I; Tian, C. Journal of Pediatric Nursing. 2021; 61:298-304.

The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy. Henson, SE; Lang, SM; Khoury, PR; Tian, C; Rutter, MM; Urbina, EM; Ryan, TD; Taylor, MD; Alsaied, T. Journal of the American Heart Association. 2021; 10.

A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial. Finkel, RS; McDonald, CM; Lee Sweeney, H; Finanger, E; Neil Knierbein, E; Wagner, KR; Mathews, KD; Marks, W; Statland, J; Nance, J; et al. Journal of Neuromuscular Diseases. 2021; 8:769-784.

Treatment of SCN4A-induced myotonic crisis. Ritter, DM; Tian, C; Broomall, E. Muscle and Nerve. 2021; 63:E59-E61.

An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids. Ferdinandusse, S; McWalter, K; te Brinke, H; IJlst, L; Mooijer, PM; Ruiter, JP N; van Lint, AE M; Pras-Raves, M; Wever, E; Millan, F; et al. Genetics in Medicine. 2021; 23:740-750.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey